Why NetEase Shares Are Trading Lower; Here Are 25 Stocks Moving Premarket

Gainers

• Ardelyx Inc (NASDAQ:ARDX) shares rose 81.2% to $2.21 in pre-market trading as the company said the FDA Advisory Committee voted 9-To-4 that the benefits of XPHOZAH outweigh its risks for the control of serum phosphorus in adult patients with chronic kidney disease on dialysis.
• Elevate Credit, Inc. (NYSE:ELVT) shares rose 65.1% to $1.75 in pre-market trading after the company agreed to be acquired by Park Cities Asset Management in an all-cash transaction at an implied value of $67 million.
• Cuentas Inc. (NASDAQ:CUEN) rose 29.6% to $0.3239 in pre-market trading after dropping 28% on Wednesday. Cuentas authorized a share repurchase program.
• Bath & Body Works, Inc. (NYSE:BBWI) rose 22.3% to $38.09 in pre-market trading after the company reported better-than-expected Q3 results and raised FY22 earnings forecast.
• SomaLogic, Inc. (NASDAQ:SLGC) rose 14.5% to $3.08 in pre-market trading. The company recently posted upbeat Q3 results and raised FY22 revenue guidance.
• The9 Limited (NASDAQ:NCTY) rose 10.8% to $0.9105 in pre-market trading. The9 is scheduled to hold its annual general meeting on December 19, 2022.
• Companhia Energética de Minas Gerais (NYSE:CIG) shares jumped 10.3% to $2.14 in pre-market trading following a 3% decline in the previous session.
• Cartesian Growth Corporation (NASDAQ:GLBL) rose 10.1% to $9.48 in pre-market trading after dropping over 15% on Wednesday.
• Satsuma Pharmaceuticals, Inc. (NASDAQ:STSA) rose 9.8% to $0.67 in pre-market trading. BML Investment Partners LP reported a 19.4% passive stake in Satsuma Pharmaceuticals as of November 14.
• Bit Brother Limited (NASDAQ:BTB) rose 9.1% to $0.1699 in pre-market trading after declining over 5% on Wednesday.
• Skillz Inc. (NYSE:SKLZ) rose 7.5% to $1.15 in pre-market trading after dropping 10% on Wednesday.
• Cisco Systems, Inc. (NASDAQ:CSCO) rose 4% to $46.16 in pre-market trading after the company reported better-than-expected Q1 results.

Don’t forget to check out our premarket coverage here .

Losers

• Fast Radius, Inc. (NASDAQ:FSRD) shares fell 23.2% to $0.1613 in pre-market trading on continued volatility after the company recently established a timeline for a Chapter 11 sale process. The company’s stock jumped 106% on Wednesday.
• Bionomics Limited (NASDAQ:BNOX) fell 15.1% to $7.20 in pre-market trading after the company reported pricing of underwritten offering of 641,026 American Depositary Shares in the U.S. at a price of $7.80 per ADS.
• SenesTech, Inc. (NASDAQ:SNES) shares fell 13.5% to $2.81 in pre-market trading. SenesTech reported pricing of $5 million public offering.
• Vaccitech plc (NASDAQ:VACC) fell 10% to $2.17 in pre-market trading. Vaccitech recently posted Q3 EPS of $0.22.
• Ensysce Biosciences, Inc. (NASDAQ:ENSC) shares fell 9.2% to $2.53 in pre-market trading after surging 29% on Wednesday.
• Ormat Technologies, Inc. (NYSE:ORA) fell 8.9% to $91.25 in pre-market trading. Ormat reported pricing of upsized public offering of 3.75 million shares of common stock on behalf of stockholder ORIX Corporation at a price of $90 per share.
• Esports Entertainment Group, Inc. (NASDAQ:GMBL) fell 8.9% to $0.1275 in pre-market trading after jumping around 12% on Wednesday.
• Blue Water Vaccines, Inc. (NASDAQ:BWV) shares fell 8.2% to $1.12 in pre-market trading after dropping 9% on Wednesday.
• Perfect Corp. (NYSE:PERF) fell 8% to $8.22 in pre-market trading after dipping 10% on Wednesday.
• Sensus Healthcare, Inc. (NASDAQ:SRTS) fell 7.8% to $6.70 in pre-market trading after dropping 7% on Wednesday.
• Sunshine Biopharma, Inc. (NASDAQ:SBFM) fell 7.3% to $0.7730 in pre-market trading. Sunshine Biopharma recently entered into a collaboration agreement with a North American lipid nanoparticle (LNP) company to advance the development of its mRNA-based anticancer macromolecule, K1.1.
• Flotek Industries, Inc. (NYSE:FTK) shares fell 6.6% to $0.99 in pre-market trading. Flotek Industries recently posted a Q3 loss of $0.25 per share.
• NetEase, Inc. (NASDAQ:NTES) shares fell 5.6% to $67.35 in pre-market trading after the company reported weak quarterly sales.